Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kamada Ltd KMDA

Healthcare Biotechnology
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:KMDA)

Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance

GlobeNewswire 9 days ago

Kamada to Announce Third Quarter and Nine-Months Ended September 30, 2024 Financial Results and Host Conference Call on November 13, 2024

GlobeNewswire November 6, 2024

Kamada to Present at the Stifel 2024 Healthcare Conference

GlobeNewswire November 4, 2024

Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston

GlobeNewswire September 23, 2024

Kamada Reports Strong Second Quarter and First Half 2024 Financial Results with Year-Over-Year 6-Month Top-Line Growth of 18% and a 68% Increase in Profitability

GlobeNewswire August 14, 2024

Kamada to Announce Second Quarter and First Half Ended June 30, 2024 Financial Results and Host Conference Call on August 14, 2024

GlobeNewswire August 7, 2024

Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance

GlobeNewswire May 8, 2024

Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

GlobeNewswire May 1, 2024

Kamada Issues 2024 CEO Letter to Shareholders

GlobeNewswire March 6, 2024
View More News ››

Opinion & Analysis (NDAQ:KMDA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:KMDA)

Trading (KMDA) With Integrated Risk Controls

News; $KMDA Trading (KMDA) With Integrated Risk Controls2024-06-17 04:18:00 ET Stock Traders Daily has produced this trading report...
whytestocks - June 17, 2024

Where is everyone ? 1st post?

This could boom on Monday and there after 
TonyRask - August 15, 2020
View more Bullboard ››

Noble Mineral Exploration Inc.

Noble Mineral Exploration Inc.

Noble Mineral Exploration Inc. is a Canada-based junior exploration company. It is engaged in the exploration and evaluation ...
View More »